Total Payments
$5,234
2024 Payments
$1,329
Companies
37
Transactions
309
Medicare Patients
3,365
Medicare Billing
$178,624
Payment Breakdown by Category
Food & Beverage$5,234 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,234 | 309 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $943.61 | 56 | $0 (2024) |
| Novo Nordisk Inc | $691.27 | 48 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $486.32 | 34 | $0 (2024) |
| GlaxoSmithKline, LLC. | $402.69 | 28 | $0 (2024) |
| PFIZER INC. | $357.22 | 15 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $274.35 | 16 | $0 (2024) |
| Astellas Pharma US Inc | $199.87 | 11 | $0 (2024) |
| Lilly USA, LLC | $172.59 | 12 | $0 (2024) |
| Merck Sharp & Dohme LLC | $168.51 | 4 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $152.41 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,329 | 73 | ABBVIE INC. ($210.87) |
| 2023 | $2,400 | 142 | ABBVIE INC. ($457.87) |
| 2022 | $1,441 | 90 | ABBVIE INC. ($274.87) |
| 2021 | $62.74 | 4 | Merck Sharp & Dohme Corporation ($34.97) |
All Payment Transactions
309 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.25 | General |
| Category: NEUROSCIENCE | ||||||
| 12/06/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/01/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: NEUROSCIENCE | ||||||
| 09/30/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: Endocrinology | ||||||
| 09/24/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: Psychology/Psychiatric | ||||||
| 09/18/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $10.23 | General |
| Category: NEUROSCIENCE | ||||||
| 08/29/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Endocrinology | ||||||
| 07/31/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/26/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: Endocrinology | ||||||
| 07/23/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: NEUROSCIENCE | ||||||
| 06/28/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: UROLOGY | ||||||
| 06/27/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $7.48 | General |
| Category: RESPIRATORY | ||||||
| 06/26/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.69 | General |
| Category: Obesity | ||||||
| 06/26/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $0.53 | General |
| Category: Obesity | ||||||
| 06/24/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $24.59 | General |
| Category: NEUROSCIENCE | ||||||
| 06/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: Diabetes | ||||||
| 06/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.05 | General |
| Category: RESPIRATORY | ||||||
| 06/12/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: Diabetes | ||||||
| 06/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: NEUROSCIENCE | ||||||
| 06/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.55 | General |
| Category: NEUROSCIENCE | ||||||
| 06/08/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Central Nervous System | ||||||
| 06/05/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/04/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: Respiratory | ||||||
| 05/29/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $28.45 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 774 | 1,686 | $165,708 | $57,804 |
| 2022 | 11 | 810 | 1,605 | $142,197 | $52,539 |
| 2021 | 14 | 881 | 1,642 | $120,236 | $39,309 |
| 2020 | 16 | 900 | 1,694 | $110,534 | $28,972 |
Total Patients
3,365
Total Services
6,627
Medicare Billing
$178,624
Procedure Codes
57
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 252 | 349 | $55,840 | $15,518 | 27.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 117 | 117 | $18,018 | $12,299 | 68.3% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 29 | 189 | $23,625 | $7,466 | 31.6% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 24 | 27 | $10,800 | $4,683 | 43.4% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 15 | 15 | $11,925 | $4,243 | 35.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 42 | 49 | $11,662 | $2,712 | 23.3% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 21 | 21 | $5,922 | $2,541 | 42.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 32 | 32 | $2,240 | $2,195 | 98.0% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 22 | 72 | $5,832 | $2,060 | 35.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 35 | 35 | $875.00 | $857.50 | 98.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 62 | 87 | $3,567 | $708.72 | 19.9% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 13 | 27 | $2,700 | $695.24 | 25.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $2,629 | $653.04 | 24.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 25 | 25 | $625.00 | $612.50 | 98.0% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 16 | 16 | $2,080 | $507.90 | 24.4% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 58 | 614 | $7,368 | $52.27 | 0.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 282 | 385 | $61,600 | $18,904 | 30.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 123 | 123 | $18,942 | $13,198 | 69.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 101 | 111 | $26,418 | $7,500 | 28.4% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 23 | 25 | $10,000 | $4,545 | 45.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 49 | 49 | $3,430 | $3,358 | 97.9% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 15 | 15 | $4,230 | $2,027 | 47.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 47 | 47 | $1,175 | $1,152 | 98.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 76 | 115 | $4,715 | $941.02 | 20.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 12 | 12 | $2,868 | $587.72 | 20.5% |
About David Hardy, FNP-C
David Hardy, FNP-C is a Family healthcare provider based in Tyler, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/24/2017. The National Provider Identifier (NPI) number assigned to this provider is 1083149397.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, David Hardy, FNP-C has received a total of $5,234 in payments from pharmaceutical and medical device companies, with $1,329 received in 2024. These payments were reported across 309 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($5,234).
As a Medicare-enrolled provider, Hardy has provided services to 3,365 Medicare beneficiaries, totaling 6,627 services with total Medicare billing of $178,624. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Tyler, TX
- Active Since 04/24/2017
- Last Updated 04/18/2024
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1083149397
Products in Payments
- LEQVIO (Drug) $341.67
- UBRELVY (Drug) $303.38
- Kerendia (Drug) $274.35
- Rybelsus (Drug) $252.22
- Wegovy (Drug) $241.79
- VRAYLAR (Drug) $222.87
- PREVNAR 20 (Biological) $215.15
- TRELEGY ELLIPTA (Drug) $204.99
- Ozempic (Drug) $180.85
- GEMTESA (Drug) $166.03
- Veozah (Drug) $150.58
- QUVIVIQ (Drug) $148.44
- ENTRESTO (Drug) $144.65
- QULIPTA (Drug) $144.13
- CREON (Drug) $122.44
- AREXVY (Drug) $103.77
- TRULICITY (Drug) $103.35
- SHINGRIX (Biological) $93.93
- ELIQUIS (Drug) $90.87
- Cologuard Collection Kit (Device) $84.53
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Tyler
Jonathan King, Np, NP
Family — Payments: $83,965
Family $83,965
Kirsten Stuber, Fnp-Bc, FNP-BC
Family — Payments: $66,199
Family $66,199
Machelle Mcdowell, Fnp, Np-C, FNP, NP-C
Family — Payments: $63,178
Family $63,178
Amanda George, Aprn, Bc Fnp, APRN, BC FNP
Family — Payments: $8,588
Family $8,588
Brandi Dunford, Fnp-C, FNP-C
Family — Payments: $6,695
Family $6,695
Tiffiney Mcmakin, Np, NP
Family — Payments: $6,483
Family $6,483